In 2007, we registered the World’s first oral antibody Animal health treatment, with the claim to “Aid in the prevention of diarrhea caused by E. coli bacteria”. This product has been sold in various countries around the world.
With any new medication, the drug regulatory agencies (FDA) are initially concerned with safety and negative side effects. The end product in our treatment is whole egg powder, with egg allergy being the only anticipated negative. Our treatment platform is considered “generally regarded as safe (gras).” by the U. S. Food and Drug Administration.
Research indicates the human gut microbiome is made up of many trillions of good and bad bacteria, and their balance has a major influence on overall health. Our oral dose therapeutic antibodies can be safely targeted at different Microbiome disease influencers to eliminate their negative effects.
In 2019 we received our letter of no objection from Health Canada to proceed with a phase 2 clinical trial of the World’s first human oral antibody treatment against C Difficile bacteria infection. This trial is ongoing, with many patients already successfully completing treatment.
We also have limited proof of concept results from people successfully treating traveler’s diarrhea, arthritis, asthma, chronic acid indigestion and IBS. These are potential pipeline target treatments.
There are many other human conditions now believed to be associated with dysbiosis of the gut Microbiome, including anxiety and depression, autism, heart disease, autoimmune disorders and cancer. These also present as potential treatments.
We also have a U. S. issued patent for the use of our special antibodies to reduce methane emissions from ruminant farm animals. This has great potential as a carbon credit application.
Finally, the world knows about Antibodies because of COVID-19, and we make Antibodies. We are confident we can apply our technology to produce Antibodies against COVID-19, as both a treatment for already infected patients and a preventive to be used like a biological mask.